Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $23.8100 (4.57%) ($20.8600 - $24.3700) on Mon. Mar. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.93% (three month average) | RSI | 35 | Latest Price | $23.8100(4.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 3.9% a day on average for past five trading days. | Weekly Trend | IOVA declines -20.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(44%) ARKK(43%) | Factors Impacting IOVA price | IOVA will decline at least -3.465% in a week (0% probabilities). VIXM(-28%) VXX(-15%) UUP(-10%) TLT(-2%) UNG(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.465% (StdDev 6.93%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
1 - 5 Day Possible Target | $-8.93(-137.51%) | Resistance Level | $29.23 | 5 Day Moving Average | $22.74(4.71%) | 10 Day Moving Average | $24.26(-1.85%) | 20 Day Moving Average | $29.23(-18.54%) | To recent high | -38.7% | To recent low | 21.9% | Market Cap | $3.487b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |